Urinary micronutrient profile as AKI biomarker in coronary angiography

  • Research type

    Research Study

  • Full title

    A pilot study to investigate urinary micronutrient profile as an early biomarker of acute kidney injury following coronary angiography

  • IRAS ID

    190342

  • Contact name

    Mark Devonald

  • Contact email

    mark.devonald@nuh.nhs.uk

  • Sponsor organisation

    Nottingham University Hospitals NHS Trust

  • Duration of Study in the UK

    1 years, 2 months, 1 days

  • Research summary

    Acute kidney injury (AKI) is the rapid deterioration in kidney function over hours or days. It is a common problem that is associated with significant morbidity and mortality and affects approximately 10-20% hospital admissions.

    AKI is currently identified using blood tests (serum creatinine levels) and urine output. Both of these are delayed markers of AKI. There is an urgent need for a reliable early test (biomarker), to allow earlier detection of AKI. In research using pigs to study AKI we have identified that urinary micronutrient profile (including amino acids, vitamins and trace elements) may have a role as a novel early biomarker of AKI. This study will investigate whether these biomarkers predict development of AKI and how serious it is.

    This study involves analysing urine samples from adult patients who have undergone a coronary angiogram (an x-ray test to look at the blood supply to the heart) following a heart attack. This group of patients is recognised to be at relatively high risk of developing AKI. It is an observational study and so will not require any extra intervention or deviation from standard care. We will take samples of urine once before and twice after the angiogram, measure the urine volume and analyse the micronutrient profile. If the patient has a urinary catheter we will take samples from the catheter every hour and measure urine output. We will review routine daily blood tests (serum creatinine) for the duration of the admission (or for 5 days and then again on discharge) to identify cases where AKI occurs. Follow up blood tests will be done on the 5th and 30th day after the test. Exceptionally an additional blood test may be required if blood tests are not measured daily.

  • REC name

    North West - Preston Research Ethics Committee

  • REC reference

    15/NW/0799

  • Date of REC Opinion

    29 Sep 2015

  • REC opinion

    Favourable Opinion